MedTrace Logo

Intensive Instruction on the Use of Aricept

NCT01972204 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2019-06-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the influence of the instruction on the use of Aricept with educational brochure on the 48-week medication persistence and to assess the reasons for discontinuation.

Conditions

  • Alzheimer's Type Dementia

Interventions

BEHAVIORAL

Intensive adherence instruction

Instruction with educational brochure

BEHAVIORAL

Control

Instruction as per usual practice

Sponsors & Collaborators

  • Mirai Iryo Research Center, Inc.

    lead OTHER

Principal Investigators

  • Tetsumasa Kamei · Shonan Fujisawa Tokushukai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01972204 on ClinicalTrials.gov